Drug recall · November 25, 2020
Testosterone Gel 1% recall
Why: Superpotent Drug: High out-of-specification assay results were obtained during stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.
- Lots / codes
Lot Number: 1351104, Exp 08/2021
- Quantity
- 12,088 cartons
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Product was distributed Nationwide in the USA.
- Initiated
- November 11, 2020 · Voluntary: Firm initiated
- Classified
- November 20, 2020
- Reported
- November 25, 2020
- Ended
- June 24, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.